-

AstraZeneca Enterprise Tech Ecosystem Profile 2024 - Digital Transformation Strategies and Innovation Programs - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Enterprise Tech Ecosystem Series: AstraZeneca Plc 2024" company profile has been added to ResearchAndMarkets.com's offering.

The report provides insights into company's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.

AstraZeneca Plc is a biopharmaceutical company, which is focused on discovery, production and commercialization of a range of prescription drugs. It develops products related to therapy areas such as respiratory, cardiovascular, renal and metabolic diseases, cancer, autoimmune, infection, and neurological diseases. The company's product portfolio includes biologics, prescription pharmaceuticals, and vaccines. AstraZeneca sells its products through wholly-owned local marketing companies, distributors, and local representative offices. The company markets its products to primary care and specialty care physicians. The company operates in Europe, the Americas, Asia, Africa, and Australasia.

The report provides information and insights into AstraZeneca's tech activities, including:

  • Insights of its digital transformation strategies and innovation programs.
  • Overview of technology initiatives covering partnerships and product launches.
  • Insights on each technology initiative including technology theme, objective, and benefits.
  • Details of estimated ICT budgets and major ICT contracts.

Reasons to Buy

  • Gain insights into AstraZeneca's tech operations.
  • Gain insights into its tech strategies and innovation initiatives.
  • Gain insights into its technology themes under focus.
  • Gain insights into various product launches and partnerships.

Key Topics Covered:

  • Overview
  • Digital Transformation Strategy
  • Accelerators, Incubators, and Innovation Programs
  • Technology Focus
  • Technology Initiatives
  • Acquisitions
  • Partnership & Acquisition Network Map
  • ICT Budget
  • Key Executives

For more information about this company profile visit https://www.researchandmarkets.com/r/q84yg9

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Industry:

Research and Markets

Release Versions
English

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Pharmaceutical Regulatory Affairs in Asia Training Course: Important Aspects of Gaining and Maintaining a Successful Marketing Authorisation (Mar 24th - Mar 26th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Regulatory Affairs in Asia Training Course (Mar 24th - Mar 26th, 2026)" training has been added to ResearchAndMarkets.com's offering. The pharmaceutical market in Asia is growing at a rapid pace and presents both opportunities and challenges to those wishing to work in the region. Rather than a single market, Asia is a collection of different markets, each with their own regulatory processes, although harmonisation exists within the ASEAN countries....

European Union Veterinary Pharmacovigilance Introductory Training Course: Practical Guidance and Basic Training for All Those Working in Drug Safety (Mar 9th - Mar 10th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Introduction to Veterinary Pharmacovigilance Training Course (Mar 9th - Mar 10th, 2026)" training has been added to ResearchAndMarkets.com's offering. This two-day event has been designed to provide an essential overview of veterinary pharmacovigilance and will offer practical guidance and basic training for all those working in drug safety in the EU. Our experienced trainer will clarify roles and responsibilities, explain commonly used terminology and take partici...

Pharma and Medical Device Clinical Quality Management Systems Training Course: EMA Guidance on Computerised Systems and ICH GCP R3 Data Governance (Mar 23rd - Mar 24th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Quality Management Systems Training Course (Mar 23rd - Mar 24th, 2026)" training has been added to ResearchAndMarkets.com's offering. This course will provide essential information and guidance to help you achieve regulatory compliance in this evolving area of clinical quality, including EMA guidance on computerised systems and ICH GCP R3 data governance. With increasing clinical quality standards required by inspectors, there is currently no harmonised re...
Back to Newsroom